| [1] |
李风，周光文．2280例肝门胆管癌的荟萃分析[J]．中华肝胆外科杂志，2013，19(3):171-176.
|
| [2] |
Khan SA, Emadossadaty S, Ladep NG, et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?[J]. J Hepatol, 2012, 56(4):848-854.
|
| [3] |
Alberts SR, Kelly JJ, Ashokkumar R, et al. Occurrence of pancreatic, biliary tract, and gallbladder cancers in Alaska native people, 1973-2007[J]. Int J Circumpolar Health, 2012 (71):17521.
|
| [4] |
王炳生，秦净，邓杰，等．上海市胆道癌诊治情况的调查和分析[J]．中华外科杂志，2005, 43(7):455-459.
|
| [5] |
Sekiya S, Suzuki A. Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes[J]. J Clin Invest, 2012, 122(11):3914-3918.
|
| [6] |
Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? a meta-analysis of risk factors for intrahepatic cholangiocarcinoma[J]. J Hepatol, 2012, 57(1):69-76.
|
| [7] |
Chapman MH, Webster GJ, Bannoo S, et al. Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience[J]. Eur J Gastroenterol Hepatol, 2012, 24(9):1051-1058.
|
| [8] |
Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma[J]. Hepatology, 2011, 54(1):173-184.
|
| [9] |
de Martel C, Plummer M, Franceschi S. Cholangiocarcinoma: descriptive epidemiology and risk factors[J]. Gastroenterol Clin Biol, 2010, 34(3):173-180.
|
| [10] |
Cai WK,Sima H,Chen BD,et al.Risk factors for hilar cholangiocarcinoma: a case-control study in China[J]. World J Gastroenterol, 2011, 17(2):249-253.
|
| [11] |
Shebl FM, Andreotti G, Meyer TE, et al. Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China[J]. Br J Cancer, 2011, 105(9):1424-1429.
|
| [12] |
Nakanuma Y, Sato Y, Harada K, et al. Pathological classification of intrahepatic cholangiocarcinoma based on a new concept[J]. World J Hepatol, 2010, 2(12):419-427.
|
| [13] |
朱珍，丛文铭．肝内胆管细胞癌的临床病理学观察[J]．临床肝胆病杂志，2013, 29(1):42-44.
|
| [14] |
Komuta M, Govaere O, Vandecaveye V, et al. Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes[J]. Hepatology, 2012, 55(6):1876-1888.
|
| [15] |
Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification[J]. J Hepatobiliary Pancreat Surg, 2003, 10(4):288-291.
|
| [16] |
Nathan H, Aloia TA, Vauthey JN, et al. A proposed staging system for intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol, 2009, 16(1):14-22.
|
| [17] |
Razumilava N, Gores GJ. Cholangiocarcinoma[J]. Lancet, 2014, 383(9935):2168-2179.
|
| [18] |
冀亮，孙备，姜洪池，等．肝门部胆管癌的手术治疗[J]．中华消化外科杂志，2013, 12(3):200-203.
|
| [19] |
Deoliveira ML, Schulick RD, Nimura Y, et al. New staging system and a registry for perihilar cholangiocarcinoma[J]. Hepatology, 2011, 53(4):1363-1371.
|
| [20] |
中华医学会外科学分会胆道外科学组，解放军全军肝胆外科专业委员会．肝门部胆管癌诊断和治疗指南(2013版)[J]．中华外科杂志，2013, 51(10):865-871.
|